NEW YORK (GenomeWeb) – The National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium (CPTAC) is partnering with the University of Victoria Genome British Columbia Proteomics Centre to develop targeted proteomic assays.

Researchers led by Christoph Borchers, director of the Proteomics Centre, will upload some 2,000 multiple reaction monitoring mass spec assays to the CPTAC Assay Portal. Borchers and his colleagues will be the first non-CPTAC researchers to upload targeted mass spec assays to the portal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.